CMP: 735

Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.

Divi's labs is well on its way to become a solid large-cap company. Its currently trading at a P/E of little over 21. Good dividend yields of 1.36% in the last 12 months at minimal liabilities. Revenues have grown steadily from 381 Crores to 1318 Crores in the last 5 years. Profits have picked up from 70 Crores to 435 Crores in the same period. NPM has gone up from 18% to an impressive 33% over 5 years. It has got solid support at 600 levels and can be accumulated on dips.